Meningitis signs in MRI
meningitis MRI signs findings radiology leptomeningeal enhancement


| Sequence | Key finding |
|---|---|
| Post-contrast T1 | Leptomeningeal enhancement |
| Post-contrast FLAIR | Most sensitive for leptomeningeal enhancement (suppresses vessels) |
| Pre-contrast FLAIR | Sulcal hyperintensity from raised CSF protein |
| DWI | Subarachnoid restricted diffusion (poor prognosis marker); also shows empyema/abscess |
| T2/FLAIR parenchyma | Cerebritis, edema, infarction |
| MRV | Venous sinus thrombosis |

| Complication | MRI Sign |
|---|---|
| Cerebritis | T2/FLAIR hyperintensity in cortex + white matter; gyral swelling; ill-defined enhancement |
| Brain abscess | Peripheral rim enhancement with central necrotic cavity (T1 dark, T2 bright); restricted diffusion in the core |
| Subdural effusion (sterile) | CSF-signal subdural collection, no enhancement |
| Subdural empyema | Intermediate T1 signal (protein-rich), restricted diffusion, pachymeningeal (dural) + leptomeningeal enhancement |
| Ventriculitis | Debris layered posteriorly in ventricles; ependymal T2 hyperintensity and contrast enhancement of the ependyma; can see intraventricular purulent material with DWI restriction |
| Hydrocephalus | Dilatation of ventricles - communicating type (blocked CSF absorption) most common; non-communicating if outlet foramina blocked |
| Infarction (arterial) | DWI restriction in large vessel territories OR perforator territories (basal ganglia, internal capsule) due to vasculitis of vessels traversing exudate |
| Venous sinus thrombosis | Loss of T2 flow void in sinus; expanded sinus; MRV filling defect; hemorrhagic venous infarct |
| Labyrinthitis ossificans (late) | T2 hypointensity in cochlear lumen post-meningitis |
Cerebellar signs in tonsillar ectopia
Chiari I malformation tonsillar ectopia cerebellar signs clinical features
| Decade of Life | Upper Limit of Normal (below foramen magnum) |
|---|---|
| 1st (children) | 6 mm |
| 2nd - 3rd | 5 mm |
| 4th - 8th | 4 mm |
| 9th | 3 mm |
| Type | Notes |
|---|---|
| Downbeat nystagmus (DBN) | Hallmark - both spontaneous and positional; may have torsional component; worse on lateral gaze |
| Positional nystagmus | |
| Primary-position unidirectional horizontal nystagmus | |
| Periodic alternating nystagmus (PAN) | |
| Rebound nystagmus (including torsional rebound) | |
| Convergence nystagmus | |
| Divergence nystagmus / divergence paralysis |
Key caveat: Despite DBN being the "classic" finding, it is rarely seen even with tonsillar herniation as striking as 20 mm. Nystagmus is difficult to appreciate even with Fresnel lens examination - Bradley & Daroff's Neurology, 12th Ed.
| System | Signs |
|---|---|
| Corticospinal | Spastic quadriparesis/paraparesis; prominent in lower limbs |
| Sensory | Sensory tract involvement in lower extremities |
| Cranial nerves (lower) | Dysphagia, hoarseness, palatal weakness (IX, X involvement) |
| Respiratory | Sleep-related breathing disorders, central apnea |
| Lower cranial nerve | Dysarthria, tongue wasting (if syringobulbia co-exists) |
| Sphincter | Bladder and bowel dysfunction (usually from syrinx) |
Tests for cerebellar signs
clinical examination tests cerebellar signs ataxia dysmetria assessment neurology
| Letter | Sign |
|---|---|
| D | Dysdiadochokinesia |
| A | Ataxia (gait/truncal) |
| N | Nystagmus |
| I | Intention tremor |
| S | Slurred (scanning) speech |
| H | Hypotonia / past-pointing |
Detecting subtle difficulty: observe patients running or walking up/down stairs - these stress the system more than level walking - Bradley & Daroff's Neurology in Clinical Practice
Balance requires input from proprioception, vestibular system, and vision. At least 2 are needed. Romberg removes vision. If the patient falls only with eyes closed, the cerebellar integration is intact but one of the other two systems is deficient - Shambaugh Surgery of the Ear
| Test | What to Look For | Implication |
|---|---|---|
| Fixation | Square-wave jerks (small involuntary saccades breaking fixation) | Common in Friedreich ataxia |
| Smooth pursuit | Saccadic (cogwheel) pursuit instead of smooth tracking | Cerebellar hemisphere dysfunction |
| Saccades | Dysmetric (hypo- or hypermetric) saccades | Multiple ataxia types |
| Gaze-evoked nystagmus | Nystagmus in eccentric gaze (end-gaze) | Many cerebellar disorders |
| Downbeat nystagmus (DBN) | Fast phase beating downward, worse on lateral gaze | Cervicomedullary junction / flocculus |
| Rebound nystagmus | Nystagmus on returning to primary gaze after sustained lateral gaze | Cerebellar |
| VOR cancellation | Ask patient to fix on their own thumb while rotating in a chair - inability to suppress VOR | Flocculonodular lobe |
| Domain | Test |
|---|---|
| 1 | Gait |
| 2 | Stance |
| 3 | Sitting |
| 4 | Speech disturbance |
| 5 | Finger chase |
| 6 | Nose-finger test |
| 7 | Fast alternating hand movements |
| 8 | Heel-shin slide |
| Sign | Localization |
|---|---|
| Gait ataxia + truncal sway | Vermis / midline (e.g., alcohol, medulloblastoma) |
| Limb dysmetria (ipsilateral) | Cerebellar hemisphere (same side as lesion) |
| Intention tremor | Cerebellar outflow (dentate nucleus / superior cerebellar peduncle) |
| Downbeat nystagmus | Flocculus / cervicomedullary junction |
| Dysdiadochokinesia | Cerebellar hemisphere |
| Scanning speech | Vermis / bilateral hemispheres |
A key principle: cerebellar signs are ipsilateral to the lesion (unlike upper motor neuron signs which cross). The patient veers toward the side of the lesion. - Bradley & Daroff's Neurology in Clinical Practice
Chiari malformation
Chiari malformation types classification pathophysiology management 2024
| Type | Definition | Key Associations |
|---|---|---|
| Type I (CM-I) | Caudal displacement of cerebellar tonsils ≥5 mm below foramen magnum; conical "peg-like" shape | Syringomyelia (50-70%); most common type; presents in adults |
| Type II (CM-II) | Displacement of cerebellar vermis, tonsils, fourth ventricle, and medulla below foramen magnum; "beaking" of midbrain | Near 100% association with myelomeningocele; hydrocephalus |
| Type III | Herniation of cerebellum into a high cervical myelomeningocele | Extremely rare |
| Type IV | Cerebellar hypoplasia/agenesis alone | Probably unrelated to other types |
| Chiari 0 | Syringomyelia with CSF flow obstruction but no tonsillar descent | Controversial subtype |
| Chiari 1.5 | Features of CM-I + brainstem herniation, but without myelomeningocele | Uncommon |
| Mechanism | Examples |
|---|---|
| "Squeeze down" - Cranial constriction | Classic CM-I, craniosynostosis, achondroplasia, Paget disease |
| "Pull down" - Spinal cord tethering | Tethered cord syndrome, CM-II |
| "Shake down" - Cranial settling | Ehlers-Danlos syndrome, connective tissue disorders, craniocervical instability |
| "Push down" - Intracranial hypertension | Hydrocephalus, posterior fossa tumors/cysts, subdural hematoma |
| "Suck down" - Intraspinal hypotension | CSF leaks, prolonged lumboperitoneal shunting, dural ectasia |



| Decade | Max normal descent |
|---|---|
| 1st | 6 mm |
| 2nd-3rd | 5 mm |
| 4th-8th | 4 mm |
| 9th | 3 mm |
| Symptom | % of Patients |
|---|---|
| Suboccipital headache (often retro-orbital; exertional/postural) | 81% |
| Ocular disturbances (floaters, blurring, photophobia, diplopia) | 78% |
| Acoustic/vestibular (dizziness, disequilibrium, tinnitus) | 74% |
| Dysesthesias (numbness, tingling, burning) | 59% |
| Chronic fatigue | 58% |
| Bulbar and coordinative problems (dysphagia, dysarthria, sleep apnea, tremor) | 52% |
| Segmental pain | 44% |
| Impaired memory/concentration | 39% |
| Cervical pain | 34% |
| Low back pain | 24% |
| Urinary incontinence | 17% |
Important mimics: multiple sclerosis, foramen magnum tumor. Onset may be acute after neck hyperextension (dental work, hairdressing, chiropractic manipulation).
| Condition | Occipital Bone | Posterior Fossa Volume | Foramen Magnum |
|---|---|---|---|
| CM-I classic | Small | Small | Small |
| CM-II (with myelodysplasia) | Small | Small | Large |
| CM-I with tethered cord | Normal | Normal | Large |
| CM-I with cranial settling | Normal | Normal | Normal |
| Approach | Indication |
|---|---|
| Observation | Asymptomatic incidental finding |
| Medical | Headache: carbonic anhydrase inhibitors, NSAIDs, head elevation, avoidance of Valsalva activities |
| Surgical - Posterior fossa decompression (PFD) | Significant functional impairment from persistent headache despite medical therapy OR progressive syringomyelia |
| Surgery NOT indicated for | Chronic fatigue alone, musculoskeletal pain, vertigo alone, prophylaxis |
Meningitis vs encephalitis clinical signs and symptoms
meningitis vs encephalitis clinical signs symptoms differences diagnosis
| Meningitis | Encephalitis | |
|---|---|---|
| Definition | Inflammation of the meninges (leptomeninges - arachnoid + pia mater) | Inflammation of the brain parenchyma itself |
| Key difference | Meningeal irritation signs dominate; brain function relatively preserved early | Brain dysfunction is the cardinal feature - altered consciousness, seizures, focal deficits |
| Overlap | When both coexist = meningoencephalitis |
"Encephalitis is inflammation of the brain parenchyma, characterized by neurologic dysfunction early in the course of illness." - Frameworks for Internal Medicine
| Symptom | Frequency |
|---|---|
| Headache | 87% |
| Neck stiffness | 83% |
| Nausea | 74% |
| Full fever + neck stiffness + AMS triad | 44% |
| Focal neurological deficits | 33% |
| Aphasia | 23% |
| Hemiparesis | 7% |
Both Kernig and Brudzinski signs have low sensitivity (~30%) individually but high specificity. Their absence does not exclude meningitis - Goldman-Cecil Medicine
| Finding | Suggests |
|---|---|
| Petechial/purpuric rash (lower body) | Meningococcemia - treat immediately |
| Waterhouse-Friderichsen syndrome (adrenal hemorrhage, shock, DIC) | Fulminant meningococcal septicemia |
| Herpes labialis | Pneumococcal meningitis |
| Preceding ear/sinus/lung infection | Pneumococcal or H. influenzae |
| Battle's sign (bruising behind ear), CSF rhinorrhea, periorbital ecchymoses | Basilar skull fracture → meningitis |
| Hyponatremia (SIADH) | H. influenzae meningitis |
| Feature | Notes |
|---|---|
| Altered consciousness | The cardinal sign - confusion, disorientation, personality change, stupor, coma; present in 70-90% of HSV encephalitis |
| Fever | Present in ~75-80% of HSV encephalitis |
| Headache | 60-70% |
| Seizures (focal or generalized) | 55% of HSV encephalitis; focal seizures are particularly suggestive |
| Personality/behavioral change | 60% - disinhibition, aggression, bizarre behavior; especially frontal/temporal lobe involvement |
| Memory disturbance | 35% - anterograde or retrograde amnesia |
| Aphasia | 40-60% (HSV - temporal lobe) |
| Motor deficits | 40% - hemiparesis, focal weakness |
| Focal neurological signs | Reflect area of brain involved |
| Photophobia | Present (shared with meningitis) |
| Neck stiffness | May be present if meninges also involved |
| Feature | Meningitis | Encephalitis |
|---|---|---|
| Primary pathology | Meningeal inflammation | Brain parenchymal inflammation |
| Fever | ✓ Very common | ✓ Very common |
| Headache | ✓ Very common (87%) | ✓ Common (60-70%) |
| Neck stiffness | ✓✓ Cardinal sign (83%) | +/- (only if meninges involved) |
| Kernig/Brudzinski | ✓ (low sensitivity ~30%) | Absent (unless meningoencephalitis) |
| Photophobia/phonophobia | ✓ Common | +/- |
| Altered consciousness | Late sign (as disease progresses) | Early, cardinal feature |
| Seizures | 20-30% (complication) | 55% (prominent early feature) |
| Focal neurological signs | 33% (complication) | Common, often early |
| Personality/behavioral change | Absent | 60% - characteristic |
| Aphasia | 23% (complication) | 40-60% (temporal involvement) |
| Memory disturbance | Absent | 35% |
| Level of consciousness | Relatively preserved initially | Impaired early |
| EEG | Normal or diffuse slowing | Focal slowing / periodic lateralized discharges (HSV) |
| MRI parenchyma | Usually normal (meningeal enhancement) | Parenchymal T2 changes (temporal lobes in HSV) |
| Rash (petechiae) | Meningococcemia | Absent |
| Parameter | Bacterial Meningitis | Viral Meningitis | Viral Encephalitis |
|---|---|---|---|
| Opening pressure | ↑↑ (>250 mm H₂O) | Normal/slight ↑ | Normal/slight ↑ |
| Appearance | Turbid/cloudy | Clear | Clear |
| WBC | >1000/µL (neutrophils) | 10-500 (lymphocytes) | 10-500 (lymphocytes) |
| Protein | ↑↑ (>1 g/L) | Slight ↑ | Slight ↑ |
| Glucose | ↓ (<2.2 mmol/L; CSF:serum <0.4) | Normal | Normal (or slight ↓) |
| Gram stain | + in 60-90% | Negative | Negative |
Thyroid eye signs
thyroid eye disease Graves ophthalmopathy named clinical signs lid retraction proptosis
https://eyewiki.org/Thyroid_Eye_Disease
NOSPECS classification thyroid eye disease clinical activity score CAS staging
| Tissue Target | Effect |
|---|---|
| Orbital fibroblasts / adipocytes | Expansion of orbital fat → proptosis |
| Extraocular muscles | Inflammation → fibrosis → restrictive myopathy |
| Eyelid tarsal muscles (Müller) | Sympathetic overactivation → lid retraction |
| Optic nerve at orbital apex | Compressed by enlarged muscles → optic neuropathy |
| Eponymous Sign | Description | Mechanism |
|---|---|---|
| Dalrymple sign | Upper eyelid retraction - sclera visible above the limbus (white scleral show at the top) | Most common sign in TED (~74-90%); Müller muscle sympathetic overactivity + levator fibrosis |
| Von Graefe sign | Lid lag on downgaze - upper lid lags behind the globe as the patient looks downward | Levator fibrosis / tethering; failure of smooth lid descent |
| Boston sign | Jerky, irregular movements of the upper eyelid on downgaze | Fibrotic lid tethering causing irregular descent |
| Stellwag sign | Incomplete and infrequent blinking + staring appearance | Lid retraction + sympathetic overactivity |
| Grove sign | Resistance to pulling the retracted upper lid downward | Fibrosis of the levator palpebrae |
| Gifford sign | Difficulty in everting the upper eyelid | Lid stiffness from infiltration |
| Gellineck sign | Abnormal pigmentation of the upper eyelid | Melanin deposition |
| Sign | Description |
|---|---|
| Enroth sign | Lower eyelid edema - puffiness of the lower lid |
| Griffith sign | Lower lid lag on upgaze - lower lid does not follow the globe upward |
| Sign | Description |
|---|---|
| Goldzeiher sign | Conjunctival injection (redness), especially over the insertions of rectus muscles |
| Chemosis | Conjunctival edema - boggy, gelatinous appearance |
| Sign | Description |
|---|---|
| Möbius sign | Poor or absent convergence |
| Ballet sign | Restriction/paralysis of one or more extraocular muscles |
| Suker sign | Poor fixation in abduction |
| Jendrassik sign | Paralysis of all extraocular muscles (severe) |
| Sign | Description |
|---|---|
| Knies sign | Uneven pupillary dilation in dim light |
| Cowen sign | Jerky pupillary light reaction |
| Sign | Description |
|---|---|
| Vigouroux sign | Eyelid fullness (periorbital soft tissue swelling) |
| Joffroy sign | Absent forehead creases on superior gaze (frontalis fails to contract because the eye can already see upward without frontalis help, due to lid retraction) |
| Rosenbach sign | Fine tremor of the closed eyelids |
| Phase | Duration | Features |
|---|---|---|
| Active/inflammatory | 6-18 months | Proptosis, retraction, chemosis, injection, pain |
| Static | Variable | Inflammation decreases, minimal improvement |
| Quiescent/fibrotic | Chronic | Fixed restrictive changes; appearance may not fully normalise |
| Class | Findings |
|---|---|
| N | No symptoms or signs |
| O | Only signs (lid retraction, stare, lid lag) |
| S | Soft tissue involvement (edema, injection, chemosis) |
| P | Proptosis (>3 mm above normal) |
| E | Extraocular muscle involvement (diplopia) |
| C | Corneal involvement |
| S | Sight loss (optic neuropathy) |
Thalassemia
thalassemia alpha beta types pathophysiology clinical features treatment 2024
| Feature | α-Thalassemia | β-Thalassemia |
|---|---|---|
| Gene | HBA1 & HBA2 on chromosome 16 | HBB on chromosome 11 |
| Gene copies | 4 α-globin genes (2 per chromosome) | 2 β-globin genes (1 per chromosome) |
| Mutation type | Mainly deletions | Mainly point mutations (>100 known) |
| Mutation classes | - | β⁰ (absent synthesis) / β⁺ (reduced synthesis) |

| System | Features |
|---|---|
| Hematologic | Severe microcytic hypochromic anemia; anisocytosis, poikilocytosis, target cells, basophilic stippling, nucleated RBCs, fragmented cells |
| Growth | Growth retardation, failure to thrive, severe cachexia (erythroid precursors steal nutrients) |
| Hepatosplenomegaly | Massive - from extramedullary hematopoiesis (spleen up to 1500 g); liver and lymph nodes also enlarged |
| Skeletal ("crew-cut" skull) | Marrow erodes cortical bone → frontal bossing, prominent cheekbones, maxillary hyperplasia; "hair-on-end" on skull X-ray; osteoporosis |
| Iron overload | Secondary hemochromatosis from transfusions + increased gut absorption |
| Cardiac | Dilated cardiomyopathy from iron deposition → leading cause of death in transfused patients |
| Hepatic | Cirrhosis, hepatic failure from iron deposition |
| Endocrine | Diabetes mellitus, hypogonadism, hypothyroidism, hypoparathyroidism (from iron in endocrine glands) |
| Infection | Increased susceptibility (functional asplenia from hypersplenism) |
| Jaundice | From ongoing hemolysis |
| Gallstones | Pigment stones from chronic hemolysis |

| Clinical State | Functional α Genes | Genotype | α-Chain Production | Features |
|---|---|---|---|---|
| Normal | 4 | αα/αα | 100% | Normal |
| Silent carrier | 3 | αα/α- | 75% | No anemia, no signs; diagnosed by molecular testing |
| α-Thalassemia trait (minor) | 2 | α-/α- or αα/-- | 50% | Mild microcytic anemia; asymptomatic; normal HbA₂ |
| HbH disease | 1 | α-/-- | 25% | Moderate-severe hemolytic anemia; β₄ tetramers (HbH); splenomegaly; worsens with oxidant stress |
| Hb Bart's / Hydrops fetalis | 0 | --/-- | 0% | Lethal - γ₄ tetramers (Hb Bart's); severe intrauterine hypoxia; stillbirth or neonatal death |
| Finding | Significance |
|---|---|
| Microcytosis + hypochromia | Reduced HbA synthesis |
| Target cells (codocytes) | Excess membrane relative to Hb content |
| Basophilic stippling | Ribosomal RNA aggregates |
| Anisocytosis / poikilocytosis | Marked variation in size and shape |
| Nucleated RBCs (normoblasts) | Stress erythropoiesis, extramedullary release |
| Heinz bodies (with supravital stain) | Precipitated HbH (in α-thalassemia) |
| Elevated reticulocyte count | But lower than expected due to ineffective erythropoiesis |
| Test | Finding |
|---|---|
| CBC | Microcytic (low MCV), hypochromic (low MCH), low Hb |
| Peripheral blood smear | Target cells, basophilic stippling, nucleated RBCs |
| Hb electrophoresis / HPLC | ↑ HbA₂ (β-thalassemia minor); ↑ HbF (major/intermedia); HbH (α-thalassemia); Hb Bart's (hydrops) |
| HbA₂ level | >3.5% = β-thalassemia trait (4-6% is classic) |
| Molecular genetic testing | Definitive - identifies specific mutations |
| Serum iron / ferritin / TIBC | Normal or elevated (distinguish from iron deficiency where ferritin is low) |
| Serum bilirubin | Elevated (hemolysis) |
Key distinction: Iron deficiency anemia vs β-thalassemia trait - both cause microcytic hypochromic anemia. Iron deficiency: ↓ ferritin, ↑ TIBC, normal HbA₂. β-thalassemia trait: normal iron stores, elevated HbA₂.
| Intervention | Details |
|---|---|
| Regular blood transfusions | Every 2-4 weeks; maintain Hb >9-10 g/dL; suppresses ineffective erythropoiesis |
| Iron chelation | Mandatory with transfusions; options: Desferrioxamine (parenteral), Deferiprone (oral), Deferasirox (oral) |
| Folic acid supplementation | For increased erythropoietic demand |
| Splenectomy | When hypersplenism increases transfusion requirements |
| Hematopoietic stem cell transplantation (HSCT) | Curative; increasing use with matched donor |
| Gene therapy | Lentiviral delivery of functional β-globin gene into patient HSCs - now approved (betibeglogene gene therapy) |
| CRISPR-based therapy | Reactivation of HbF production (e.g., Casgevy - approved for transfusion-dependent β-thalassemia) |
Sick sinus syndrome
sick sinus syndrome pathophysiology clinical features ECG management pacemaker
| Arrhythmia | Description |
|---|---|
| Inappropriate sinus bradycardia | HR <60 bpm not explained by physiology (drugs, fitness, sleep) |
| Sinus arrest | SA node fails to fire; atrial asystole (no P waves); pauses >3 sec during daytime are pathological |
| Sinoatrial (SA) exit block | SA node fires but impulse fails to traverse perinodal tissue; PP interval is a multiple of the basic PP interval |
| Tachycardia-bradycardia (tachy-brady) syndrome | Alternating paroxysmal atrial tachyarrhythmias (AF, flutter, SVT) and bradycardia; most dangerous - sudden pause after tachycardia termination |
| Chronotropic incompetence | Inability to increase heart rate appropriately with exercise; max HR <100 bpm on exercise |
| Atrial fibrillation with slow ventricular response | Indicates combined SA and AV nodal disease |



| Type | ECG Pattern |
|---|---|
| 1st degree | Cannot be seen on surface ECG (delayed but not blocked) |
| 2nd degree Type I (Wenckebach) | Progressive PP shortening → pause; pause <2x shortest PP |
| 2nd degree Type II | Pause = exact multiple of basic PP interval (constant PP before and after) |
| 3rd degree (complete) | Complete absence of sinus P waves |
| Category | Examples |
|---|---|
| Degenerative/fibrotic | Age-related fibrosis of the SA node (most common) - sclerodegenerative process involving SA node, AV node, bundle of His |
| Ischemic | RCA occlusion (SA node artery is a branch of RCA in ~60%), acute MI |
| Cardiomyopathy | Dilated, hypertrophic |
| Inflammatory | Myocarditis, pericarditis |
| Infiltrative | Amyloidosis, sarcoidosis, hemochromatosis |
| Surgical | Post-cardiac surgery (especially Mustard/Fontan procedures for congenital heart disease) |
| Congenital | SA node structural abnormalities |
| Category | Examples |
|---|---|
| Autonomic | Excessive vagal tone (athletes, vasovagal, carotid sinus hypersensitivity) |
| Drugs | Beta-blockers, calcium channel blockers (diltiazem, verapamil), digoxin, amiodarone, ivabradine, antiarrhythmics (class I) |
| Metabolic | Hypothyroidism, hypothermia, hypoxia, hypo/hyperkalemia |
| Raised ICP | Cushing reflex |
| Sleep apnea | Nocturnal pauses (physiologic at night) |
| Gene | Product | Mechanism |
|---|---|---|
| SCN5A | Nav1.5 (cardiac sodium channel) | Loss-of-function → reduced automaticity; can co-present with Brugada, CCD, LQT3 |
| HCN4 | I_f "funny" pacemaker current | Loss-of-function → impaired automaticity; can cause severe bradycardia + TdP |
| ANK2 | Ankyrin-B (membrane adaptor) | Disrupts ion channel localization |
| MYH6 | Alpha-myosin heavy chain | Structural SA node disease |
| Symptom | Notes |
|---|---|
| Fatigue, exercise intolerance | Most common; from chronotropic incompetence |
| Dizziness, lightheadedness | Transient cerebral hypoperfusion |
| Pre-syncope / syncope | Prolonged pauses (tachy-brady) - most dangerous presentation |
| Palpitations | From tachyarrhythmia component |
| Worsening heart failure | From low output |
| Stroke / TIA | From AF component (thromboembolic risk) |
Important: Symptoms must correlate with ECG findings. ECG abnormalities without symptoms are not sufficient for SSS diagnosis. Bradycardia during sleep or in athletes may be physiologic.
| Test | Use |
|---|---|
| 12-lead ECG | Sinus bradycardia, pauses, SA exit block; often normal between episodes |
| 24-48 hour Holter monitoring | First-line for frequent symptoms |
| Extended ambulatory ECG (2-4 weeks) | For infrequent symptoms |
| Implantable loop recorder (ILR) | Gold standard for very infrequent syncope; records up to 3 years |
| Exercise stress test | Reveals chronotropic incompetence |
| Electrophysiology (EP) study | Sinus node recovery time (SNRT); corrected SNRT >550 ms = abnormal; SA conduction time; less sensitive than monitoring |
| Carotid sinus massage | Assess carotid sinus hypersensitivity |
| Thyroid function, electrolytes | Exclude reversible causes |
| Drug review | Identify causative medications |
| Mode | Use |
|---|---|
| AAIR (atrial pacing, rate-adaptive) | SSS without AV block; preserves normal AV conduction |
| DDDR (dual-chamber, rate-adaptive) | Preferred - SSS with risk of AV block (common in SND); reduces AF risk vs ventricular-only pacing |
| Minimize RV pacing | Dual-chamber devices that minimize unnecessary RV pacing reduce AF incidence and HF risk |
Key principle: Atrial pacing is preferred over ventricular pacing in SSS - reduces AF risk and preserves AV synchrony. Dual-chamber pacing is recommended because of the ~15-20% rate of associated AV block in SND - Braunwald's Heart Disease
Levosulpride effect on blood pressure
levosulpiride effect on blood pressure hypertension hypotension mechanism
Find recent clinical guidelines on thyroid disorders